Biggest News Aggregation in the World
📰 Devon Christie News

Page 2 - Devon Christie News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Devon Christie. Real-time updates on events, politics, business and more.

Numinus Wellness Inc. congratulates MAPP1 trial study team on announcement of results from the Phase 3 randomized clinical trial of MDMA-assisted therapy for the treatment of severe post-traumatic stress disorder (PTSD)

 Numinus Wellness congratulates study team on announcement of results from Phase 3 randomized clinical trial of MDMA-assisted therapy for treatment of severe PTSD The trial, which involved 90 participants with chronic PTSD, demonstrated that 88% of participants who received three controlled and supervised MDMA-assisted therapy sessions experienced a clinically significant reduction in symptoms, with 67% no longer qualifying for PTSD diagnosis in comparison to 32% of participants randomized to...
Payton Nyquvest Devon Christie Multidisciplinary Association For Psychedelic Studies Drug Administration Health Canada Public Benefit Corporation

Non-Traditional Therapies Could Fill Vital Mental Health Needs

Non-Traditional Therapies Could Fill Vital Mental Health Needs - FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 2, 2021 /PRNewswire/ -- Non-traditional therapies are coming a long way from their stigmatized roots. Rising rates of serious mental health issues and unreliability of traditional mental health treatments have spurred research into treatment forms utilizing once stigmatized and criminalized drugs. The results have been promising enough that the pharmaceuti...
Payton Nyquvest Kostenloser Wertpapierhandel Devon Christie Numinus Bioscience Numinus Wellness Inc Multidisciplinary Association For Psychedelic Studies

Canadian Government Agency Removes Barrier for Psilocybin Therapy

In other industry news of note: Mydecine Innovations Group (CSE:MYCO) (MYCO.CNQ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, recently announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group will provide re...
Ben Nikolaevsky Josh Bartch Devon Christie Entheon Biomedical Corp Fn Media Group Mindspace Psychology Services Inc

Financial News Media | Canadian Government Agency Removes Barrier for Psilocybin Therapy

Palm Beach, FL – December 16, 2020 – Health Canada, in a recent “breakthrough Exemption” has quietly expanded its list of who can legally possess and consume psilocybin-containing mushrooms by granting 16 health-care professionals the same exemptions it gave more than a dozen patients with terminal and mental illnesses, according to TheraPsil, a Victoria non-profit that has been behind the struggle to treat a list of mental health issues, including debilitating depression, PTSD and eve...
Ben Nikolaevsky Josh Bartch Devon Christie Entheon Biomedical Corp Fn Media Group Mindspace Psychology Services Inc

Baystreet.ca - Psychedelic Drugs Could Create a $100 Billion Investment Opportunity

Psychedelic Drugs Could Create a $100 Billion Investment Opportunity With psychedelic drugs showing promise with mental health issues, investors have just begun to push into a space that could be worth up to $100 billion, according to Tania Gonsalves, analyst for Canaccord Genuity Capital Markets, as quoted by Psychedlic Spotlight. She added, “the companies that will emerge as the winners "will have deep pockets, patentable products and a well-thought-out reimbursement strategy." Hel...
United States British Columbia Payton Nyquvest Tania Gonsalves Devon Christie Joe Flanders

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

Share:   First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approval  VANCOUVER, BC, Dec. 11, 2020 /CNW/ - .  ("Numinus" or the "Company") (TSXV:NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, commends Health Canadas leadership for its intention to revise the Special Access Programme (S...
British Columbia Payton Nyquvest Evan Wood Devon Christie Numinus Bioscience Health Canada Special Access Programme

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science